Eugia Pharma Specialities Limited

Eugia Pharma Specialities Limited - pharma in Ameerpet, Telangana, India. FY 2026 financials and compliance.
CIN U24297TG2013PLC087048 Incorporated 17 April 2013 ROC Hyderabad HQ Ameerpet, Telangana, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹4,828.71 Cr
▲ 12.00% YoY
EBITDA · FY 2025
*****
▲ 25.00% YoY
Net profit · FY 2025
*****
▲ 49.00% YoY
Authorised capital
₹800 Cr
Registered with MCA
Paid-up capital
₹621.01 Cr
Issued & subscribed
Open charges
None
Satisfied ₹724 Cr
Company age
13 yrs
Est. 2013
Employees · EPFO
2,763
Latest available

About Eugia Pharma Specialities Limited

Data last updated: 06 January 2026

Eugia Pharma Specialities Limited is a public limited company based in Ameerpet, Telangana, India, a subsidiary of Aurobindo Pharma Ltd. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 17 April 2013, the company has been in operation for over 13 years.

Registered with ROC Hyderabad under CIN U24297AP2013PLC087048.

Capital: an authorised share capital of ₹800 Cr and a paid-up capital of ₹621.01 Cr. It is led by directors including Madan Mohan Reddy Mettu and Veerayya Chowdary Kosaraju.

Last AGM: 08 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No.2 Maitrivihar, Ameerpet, Telangana, India – 500038.

As per the financials filed for FY 2025, the company reported a revenue of ₹4,828.71 Cr, a growth of 12% compared to the previous year.

The company has a workforce of approximately 2,763 employees as per the latest available data. It operates as a subsidiary of Aurobindo Pharma Ltd.

As per MCA filings, the company has satisfied charges of ₹724 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eugiapharma.com.

Company Details of Eugia Pharma Specialities Limited
CIN U24297TG2013PLC087048
Registration Number 087048
Incorporation Date 17 April 2013
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 08 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Aurobindo Pharma Ltd
Compliance Status Active Compliant
Key People
Yugandhar Puvvala Ceo Madan Mohan Reddy Mettu Director Veerayya Chowdary Kosaraju Director
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
  • Registered Address
    Plot No.2 Maitrivihar, Ameerpet, Telangana, India – 500038
  • Industry
    Pharma, Drug Formulation & Development
Company report
Eugia Pharma Specialities Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Eugia Pharma Specialities Limited report

Financials, compliance, directors, charges, ownership and filings for Eugia Pharma Specialities Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Eugia Pharma Specialities Limited

Eugia Pharma Specialities Limited has one previous CIN (Corporate Identification Number): U24297AP2013PLC087048. The current CIN is U24297TG2013PLC087048, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24297TG2013PLC087048 Current
U24297AP2013PLC087048 Previous

Business Activity of Eugia Pharma Specialities Limited

Eugia Pharma Specialities Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Board of Directors of Eugia Pharma Specialities Limited

Eugia Pharma Specialities Limited is currently managed by 8 directors, with 24 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Madan Mohan Reddy Mettu
Also directs: Mss Packaging Industries Llp, Aurobindo Pharma Ltd, Engenra Biologics Private Limited and 5 more
Director 17 Apr 2013 13 Years 2 Months Current
Veerayya Chowdary Kosaraju
Also directs: Ccl Products (India) Limited, Reliance Industries Limited, Divi's Laboratories Limited and 5 more
Director 01 Dec 2021 4 Years 7 Months Current
Yugandhar Puvvala Ceo 01 Oct 2021 4 Years 9 Months Current
Santhanam Subramanian
Also directs: Aurobindo Pharma Ltd, Engenra Biologics Private Limited, Theranym Biologics Private Limited and 5 more
Director 01 Oct 2021 4 Years 9 Months Current
Ragunathan Kannan
Also directs: K Vijayaraghavan & Associates Llp, Premier Energies Limited, Transcon Ind Limited and 5 more
Director 01 Dec 2021 4 Years 7 Months Current
Sundari Raviprasad Pisupati
Also directs: Rainbow Children's Medicare Limited, Rainbow Speciality Hospitals Private Limited, Pratiksha Women & Child Care Hospital Private Limited
Director 01 Dec 2021 4 Years 7 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Eugia Pharma Specialities Limited FY 2025 filings available

Eugia Pharma Specialities Limited reported revenue of ₹4,828.71 Cr (up 12% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹4,828.71 Cr ▲ 12%
Profit
***** ▲ 49%
EBITDA
***** ▲ 25%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Eugia Pharma Specialities Limited

Open charges
₹0
Satisfied charges
₹724 Cr
Breakdown by lending institutions
Others₹605.00 Cr
Export Import Bank of India₹119.00 Cr
Latest charge details
DateLenderAmountStatus
27 Sep 2019 Others ₹105 Cr Satisfied
06 Jul 2017 Others ₹500 Cr Satisfied
24 Feb 2014 Export Import Bank of India ₹119 Cr Satisfied

Total charge records: 3 View all charges

Employees and EPFO Compliance at Eugia Pharma Specialities Limited

View historical data on people associated with Eugia Pharma Specialities Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Eugia Pharma Specialities Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Eugia Pharma Specialities Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Eugia Pharma Specialities Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Eugia Pharma Specialities Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Eugia Pharma Specialities Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Eugia Pharma Specialities Limited

MSME Payment Delays by Eugia Pharma Specialities Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Eugia Pharma Specialities Limited

Subsidiaries & Group Companies of Eugia Pharma Specialities Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Eugia Pharma Specialities Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Eugia Pharma Specialities Limited

MCA Filings & Documents of Eugia Pharma Specialities Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Eugia Pharma Specialities Limited

Activity
08 Sep 2025
Eugia Pharma Specialities Limited last Annual general meeting of members was held on 08 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Eugia Pharma Specialities Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Directors
21 Feb 2024
Vallamkondu Aravind Kumar was appointed as a Cfo on 21 Feb 2024 & has been associated with this company since 2 years 4 months.
Charges
04 Mar 2022
A charge registered on 27 Sep 2019 via Charge ID 100295568 with Others was fully satisfied on 04 Mar 2022.
Directors
27 Dec 2021
Yugandhar Puvvala was appointed as a CEO on 27 Dec 2021 & has been associated with this company since 4 years 6 months.
Directors
01 Dec 2021
Veerayya Chowdary Kosaraju was appointed as a Director on 01 Dec 2021 & has been associated with this company since 4 years 7 months.

Recent News on Eugia Pharma Specialities Limited

Frequently Asked Questions about Eugia Pharma Specialities Limited

Eugia Pharma Specialities Limited is an active public limited company in the pharma sector based in Ameerpet, Telangana, India. It was incorporated on 17 April 2013 (13+ years old) and is registered under CIN U24297TG2013PLC087048. The company has 2,763 employees.

Eugia Pharma Specialities Limited reported revenue of ₹4,828.71 Cr for FY 2025 (up 12.00% YoY).

The current directors of Eugia Pharma Specialities Limited are:

The primary industry of Eugia Pharma Specialities Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Eugia Pharma Specialities Limited can be reached at the registered office: Plot No.2 Maitrivihar, Ameerpet, Telangana, India – 500038, or through the website eugiapharma.com.

The authorised capital is ₹800 Cr, and the paid-up capital is ₹621.01 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available